Skip to main content
. 2023 Jul 12;14:1230533. doi: 10.3389/fmicb.2023.1230533

FIGURE 7.

FIGURE 7

Human immunodeficiency virus type one (HIV-1)-RT-LAMP-AuNPs-LFA assay specificity with different strains. Assay specificity was evaluated using different nucleic acid templates. Amplification products were tested using AuNPs-LFA: 1–4, HIV-1 CRF01_AE, CRF07_BC, CRF08_BC, and subtype B pol plasmids; 5-11, HIV-1 clinical samples; 12, hepatitis B virus; 13, hepatitis C virus; 14, influenza A virus; 15, influenza B virus; 16, Coxsackie virus CAV16; 17, human enterovirus EV71; 18, human papillomavirus; 19, Epstein-Barr virus; 20, Mycobacterium tuberculosis; 21, Streptococcus pneumoniae; 22, Pseudomonas aeruginosa; 23, Chlamydia trachomatis; 24, Neisseria gonorrhoeae; 25, Ureaplasma urealyticum; 26, Staphylococcus aureus; 27, Escherichia coli; 28, Enterococcus faecalis; 29, Cryptococcus neoformans; 30, Shigella boydii; 31, Streptococcus glabra; 32, Haemophilus influenzae; 33, Streptococcus albus; 34, Stenotrophomonas maltophilia; 35, Salmonella typhimurium; 36, Salmonella enteritidis; 37, Acinetobacter lwoffii; 38, Enterobacter aerogenes; 39, Brucella; 40, distilled water (Blank control). CL, control line; TL, test line.